Gaucher Disease Type 3
📧 Sign up to get email alerts when something new happens for Gaucher Disease Type 3.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2023-08-09Clinical Trial Update: An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3 [Phase 2, Phase 3]
A clinical trial evaluating AVR-RD-02 for Gaucher disease type 3 was withdrawn after being studied in Phase 2/3.
-
CLINICAL_TRIALS research · 2022-07-27Clinical Trial Update: Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease [Phase 1, Phase 2]
Phase 1/2 clinical trial update for CAN103 in Gaucher disease (Type 1 and Type 3) by CANbridge.
-
CLINICAL_TRIALS withdrawal · 2018-03-02Clinical Trial Update: The Effect of Velaglucerase Alfa (Vpriv) on Skeletal Development in Pediatric Gaucher Disease [Phase 4]
Phase 4 pediatric trial evaluating the effect of Velaglucerase alfa on skeletal development in Gaucher disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease [Phase 1, Phase 2]
Clinical trial updates the efficacy and safety of velaglucerase alfa in children and adolescents with Type 3 Gaucher disease, completed with…